Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in CTKB — Cytek Biosciences, Inc.

CIK 1387508 NEW YORK, NY

Position in CTKB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$200,497
+$142,813 QoQ
Shares Held
45,259
+242.9% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#70
of 154 holders
Holding Since
Mar 2023
9 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in CTKB Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $16,970,515 across 13 Medical Devices names. CTKB ranks #10 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CTKB

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $200,497 45,259
2026-03-31 $57,684 13,200
2025-12-31 $67,670 13,400
2025-03-31 $76,992 19,200
2024-12-31 $187,431 28,880
2024-09-30 $198,797 35,884
2024-06-30 $94,380 16,914
2024-03-31 $106,018 15,800
2023-03-31 $167,000 18,172